Literature DB >> 26039830

The influence of end-stage liver disease and liver transplantation on thyroid hormones.

Karla Rocha Penteado1, Júlio Cezar Uili Coelho2, Mônica Beatriz Parolin1, Jorge Eduardo Fouto Matias2, Alexandre Coutinho Teixeira de Freitas2.   

Abstract

BACKGROUND: Thyroid dysfunction has been reported in most chronic illnesses including severe liver disease. These defects in thyroid hormone metabolism result in the sick euthyroid syndrome, also known as low T3 syndrome.
OBJECTIVES: Our objective was to evaluate the thyroid function in patients with end stage liver disease prior and after deceased donor liver transplantation and to correlate thyroid hormonal changes with the MELD score (Model for End stage Liver Disease).
METHODS: In a prospective study, serum levels of thyrotropin (thyroid stimulating hormone TSH), total thyroxine (tT4), free thyroxine (fT4) and triiodothyronine (T3) from 30 male adult patients with end stage liver disease were measured two to four hours before and 6 months after liver transplantation (LT). MELD was determined on the day of transplant. For this analysis, extra points were not added for patients with hepatocellular carcinoma.
RESULTS: The patients had normal TSH and fT4 levels before LT and there was no change after the procedure. Total thyroxine and triiodothyronine were within the normal range before LT, except for four patients (13.3%) whose values were lower. Both hormones increased to normal values in all four patients after LT (P=0.02 and P<0.001, respectively). When the patients were divided into two groups (MELD <18 and MELD >18), it was observed that there was no change in the TSH, freeT4, and total T4 levels in both groups after LT. Although there was no significant variation in the level of T3 in MELD <18 group (P=0.055), there was an increase in the MELD >18 group after LT (P=0.003).
CONCLUSION: Patients with end stage liver disease subjected to liver transplantation had normal TSH and fT4 levels before and after LT. In a few patients with lower tT4 and T3 levels before LT, the level of these hormones increased to normal after LT.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26039830     DOI: 10.1590/S0004-28032015000200009

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  4 in total

1.  The impact of serum thyroid-stimulation hormone levels on the outcome of hepatitis B virus related acute-on-chronic liver failure: an observational study.

Authors:  Jun-Feng Chen; Wei-Zhen Weng; Miao Huang; Xiao-Hua Peng; Jing Zhang; Jing Xiong; Jian-Rong He; Shao-Quan Zhang; Hui-Juan Cao; Bin Gao; Deng-Na Lin; Juan Gao; Zhi-Liang Gao; Bing-Liang Lin
Journal:  BMC Gastroenterol       Date:  2022-07-07       Impact factor: 2.847

2.  The Pattern of Dyslipidemia in Chronic Liver Disease Patients.

Authors:  Umar Farooque; Ashok Kumar Lohano; Quratulain Dahri; Nazia Arain; Fnu Farukhuddin; Chinmay Khadke; Febin Prince; Rizwan Farooque; Mostafa A Shehata; Muhammad Daim Bin Zafar
Journal:  Cureus       Date:  2021-02-10

3.  Low T3 syndrome as a prognostic factor in patients in the intensive care unit: an observational cohort study.

Authors:  Carla Daniele Nascimento Pontes; Juliane Lúcia Gomes da Rocha; Janaina Maria Rodrigues Medeiros; Bruno Fernando Barros Dos Santos; Paulo Henrique Monteiro da Silva; Janine Maria Rodrigues Medeiros; Gabriela Góes Costa; Isabella Mesquita Sfair Silva; Daniel Libonati Gomes; Flávia Marques Santos; Rosana Maria Feio Libonati
Journal:  Rev Bras Ter Intensiva       Date:  2022 Apr-Jun

4.  Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?

Authors:  Tolga Sahin; Alihan Oral; Fatih Turker; Erdem Kocak
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.